US Stock MarketDetailed Quotes

CTNM Contineum Therapeutics

Watchlist
  • 14.340
  • +0.690+5.05%
Close Nov 21 16:00 ET
  • 14.340
  • 0.0000.00%
Post 16:00 ET
369.65MMarket Cap-12769P/E (TTM)

About Contineum Therapeutics Company

Contineum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. The company was founded by Daniel S. Lorrain on May 9, 2017 and is headquartered in San Diego, CA.

Company Profile

SymbolCTNM
Company NameContineum Therapeutics
Listing DateApr 5, 2024
Issue Price16.00
Founded2017
CEOMr. Carmine Stengone
MarketNASDAQ
Employees31
Fiscal Year Ends12-31
Address3565 General Atomics Court,Suite 200
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-333-5280
Websitehttp://www.contineum-tx.com

Company Executives

  • Name
  • Position
  • Salary
  • Carmine Stengone
  • Chief Executive Officer, President and Chairman of the Board
  • 2.32M
  • Peter T. Slover
  • Chief Financial Officer and Principal Accounting Officer
  • 1.03M
  • Daniel S. Lorrain, PhD
  • Chief Science Officer
  • 1.79M
  • Stephen L. Huhn, M.D.
  • Chief Medical Officer and Senior Vice President, Clinical Development
  • --
  • Sarah Boyce
  • Independent Director
  • --
  • Olivia C. Ware, M.B.A.
  • Independent Director
  • --
  • Lori Lyons-Williams
  • Independent Director
  • 25.00K
  • Evert B. Schimmelpennink
  • Independent Director
  • 23.82K
  • Troy A. Ignelzi
  • Independent Director
  • --
  • Dr. Todd C. Brady, M.D.,PhD
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data